Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | -1.11% | -8.25% | -21.93% |
May. 15 | Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT | CI |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 59.43M | |
+8.85% | 222B | |
+13.62% | 195B | |
+23.17% | 148B | |
+32.85% | 113B | |
+4.18% | 66.45B | |
+13.08% | 53.11B | |
+3.16% | 50.03B | |
-4.65% | 38.8B | |
-2.17% | 34.85B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems' VISABL-AFL Trial Obtains Lausanne University Hospital Ethics Approval; Shares Up 8%